In MAPTP301S PS19 mouse model of tauopathy, clearance of p16INK4A-positive senescent astrocytes and microglia by using INK-ATTAC transgenic mice attenuates gliosis, tau hyperphosphorylation, and neurodegeneration [239]. The gene discussed is CDKN2A; the disease is tauopathy.